Hippo

Hippo’s gross loss ratio remained unchanged at 76% and its net loss ratio rose 23 points to 273% as the InsurTech was hit by catastrophic events in Q1, mainly in California.

The company expects to turn adjusted Ebidta positive by the end of 2024 with cash of at least $400mn.

The InsurTech said it had raised its per occurrence limit by 32%.

2022 marked a reversal from last year’s unprecedented levels of global investment in InsurTech as the macroeconomic scenario flipped and investors put lossmaking companies under a magnifying glass.

InsurTechs’ mounting losses and continuing cash burn combined with reinsurance market hardening could spell trouble for the sector.

Our Trump/Biden note from yesterday discussed the rotation from growth stocks to value stocks playing out over 2022. Unfortunately, insurance technology stocks have had it the worst, with Lemonade stock down 49%, but still doing relatively better than Root (down 86%) and Hippo (down 80%).

Inside P&C’s morning summary of the key stories to get you up to speed fast.

CEO Rick McCathron said he is not concerned about reinsurance supply, as the company has multi-year capacity with partners and has improved loss ratios.

The gross and net losses represented 52 points of the gross loss ratio and 44 points of the net loss ratio.

As ITC Vegas begins, the Inside P&C Research team explores the discussions needed among InsurTechs to address questions around capital, partnerships, and profitability prospects.

The InsurTech’s stock price was down as much as 9% in after-hours trading following the announcement.

Inside P&C’s morning summary of the key stories to get you up to speed fast.